rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
2010-9-29
|
pubmed:abstractText |
We postulated that combining high-dose simvastatin with bone marrow derived-mesenchymal stem cells (MSCs) delivery may give better prognosis in a mouse hindlimb ischemia model.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1423-0127
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
75
|
pubmed:meshHeading |
pubmed-meshheading:20846454-Analysis of Variance,
pubmed-meshheading:20846454-Animals,
pubmed-meshheading:20846454-Apoptosis,
pubmed-meshheading:20846454-Blotting, Western,
pubmed-meshheading:20846454-Combined Modality Therapy,
pubmed-meshheading:20846454-Female,
pubmed-meshheading:20846454-Flow Cytometry,
pubmed-meshheading:20846454-Hindlimb,
pubmed-meshheading:20846454-Immunohistochemistry,
pubmed-meshheading:20846454-Ischemia,
pubmed-meshheading:20846454-Laser-Doppler Flowmetry,
pubmed-meshheading:20846454-Male,
pubmed-meshheading:20846454-Mesenchymal Stem Cell Transplantation,
pubmed-meshheading:20846454-Mesenchymal Stem Cells,
pubmed-meshheading:20846454-Mice,
pubmed-meshheading:20846454-Mice, Inbred C57BL,
pubmed-meshheading:20846454-Neovascularization, Physiologic,
pubmed-meshheading:20846454-Rats,
pubmed-meshheading:20846454-Rats, Sprague-Dawley,
pubmed-meshheading:20846454-Regional Blood Flow,
pubmed-meshheading:20846454-Simvastatin,
pubmed-meshheading:20846454-Vascular Endothelial Growth Factor A
|
pubmed:year |
2010
|
pubmed:articleTitle |
Augmentation of neovascularization in murine hindlimb ischemia by combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells transplantation.
|
pubmed:affiliation |
Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, RR China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|